glp-1 and seizures Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy associated comorbidities I believe in body autonomy.
Description
The integration of kinase (PKA, CDK5, GSK3) and small G-protein (IQGAP1) signalling pathways through CaMKK2, all of which have demonstrated links with human bipolar disorder, points to the possibility that bipolar disorder is a signalopathy that stems from defects in this signal transduction network, and potentially explains the clinical heterogeneity and polygenic nature of the condition
2020, 8 (March), 111
Cardiovascular Risk Reduction: Beyond Weight and Diabetes The LEADER, SUSTAIN-6, and REWIND trials established that GLP-1 agonists reduce major adverse cardiovascular events in patients with established heart disease or multiple risk factors
Bloating is often most noticeable in the first few weeks or after a dose increase
Table 1 summarizes the RCTs that measured the weight-reducing effects and the other secondary outcomes of GLP-1RA in PCOS patients
